光莆股份 reported revenue of ¥0.38B for the period ended 2026-06-30, -4.3% year on year. Net income was ¥-0.02B, a -6.0% net margin on a 25.1% gross margin. The largest revenue line is 半导体光应用 at 77% of the total. Free cash flow for the period was ¥0.01B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.38B | -4.3% |
| Gross profit | ¥0.10B | — |
| Operating income | ¥-0.03B | — |
| Net income | ¥-0.02B | -223.2% |
| Gross margin | 25.1% | Net margin -6.0% |
| Revenue Q/Q | +0.6% | — |
| Segment | Revenue | Share |
|---|---|---|
| 半导体光应用 | ¥0.29B | 76.7% |
| 医疗美容 | ¥0.05B | 12.0% |
| FPC(柔性电路板) | ¥0.04B | 9.7% |
| 其他(补充) | ¥0.01B | 1.7% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.29B | 74.9% |
| R&D | ¥0.03B | 7.1% |
| SG&A | ¥0.08B | 21.8% |
| Tax & other | ¥-0.00B | -1.1% |
| Item | Amount |
|---|---|
| Total assets | ¥2.70B |
| Total liabilities | ¥1.01B |
| Shareholders' equity | ¥1.69B |
| Equity / assets | 62.4% |
| Operating cash flow | ¥0.03B |
| Capital expenditure | ¥0.02B |
| Free cash flow | ¥0.01B |
| Cash conversion (OCF / net income) | -51% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
开立医疗 ・ 彩讯股份 ・ 中达安 ・ 同和药业 ・ 扬帆新材 ・ 广和通 ・ 凯普生物 ・ 德艺文创 ・ 正丹股份 ・ 透景生命 ・ 万通智控 ・ 南京聚隆
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies